NEULAND LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Neuland Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.60₹ -85.55
As on Jan 14, 2026, 4:01 PM IST
Neuland Laboratories Price Performance
Today's LowToday's High
₹14,159.20₹14,710.20
₹14,247.55
52 Weeks' Low52 Weeks' High
₹10,060.00₹19,748.40
₹14,247.55
Open Price
₹14,159.20
Prev. Close
₹14,333.10
Volume
2,169
Over the last 5 years, the share price of Neuland Laboratories has gained 62.69% CAGR. Over the past year, the corresponding return has been 7.21%.
Neuland Laboratories’s current P/E of 76.12x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Neuland Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Neuland Laboratories | -5.78 | -13.24 | -12.55 | -2.42 | 7.21 | 104.47 | 62.69 |
| Sun Pharmaceutical Industries | -4.60 | -5.38 | 2.81 | 1.10 | -3.86 | 17.98 | 22.88 |
| Divi's Laboratories | -4.39 | 0.06 | -3.18 | -6.38 | 5.88 | 23.97 | 11.26 |
| Torrent Pharmaceuticals | -2.15 | 5.88 | 13.75 | 17.50 | 23.01 | 36.63 | 23.48 |
| Cipla | -2.23 | -4.82 | -7.63 | -3.37 | -0.93 | 10.61 | 11.29 |
| Lupin | -0.84 | 5.02 | 13.28 | 14.04 | 1.84 | 42.61 | 14.70 |
| Dr. Reddy's Laboratories | -4.08 | -6.91 | -3.66 | -4.72 | -10.87 | 11.27 | 2.34 |
| Mankind Pharma | -3.01 | 4.62 | -7.96 | -16.96 | -16.08 | 16.33 | 9.50 |
| Zydus Lifesciences | -4.61 | -3.99 | -9.67 | -8.67 | -11.62 | 26.30 | 11.94 |
| Alkem Laboratories | 0.49 | 3.60 | 5.89 | 20.20 | 10.36 | 24.18 | 13.32 |
| Aurobindo Pharma | -4.19 | -0.17 | 5.35 | 3.93 | 0.73 | 38.42 | 4.29 |
| Abbott India | -2.05 | 0.05 | -7.29 | -18.84 | -1.22 | 8.19 | 13.21 |
| Laurus Labs | -3.34 | 8.63 | 24.47 | 32.37 | 91.99 | 45.49 | 24.34 |
| Biocon | -2.12 | -2.96 | 7.75 | -0.05 | -2.24 | 14.80 | -4.08 |
| Glenmark Pharmaceuticals | -4.88 | 1.24 | 6.14 | -9.39 | 32.68 | 68.53 | 31.03 |
| GlaxoSmithKline Pharmaceuticals | -2.89 | -7.31 | -13.62 | -25.11 | 14.90 | 22.37 | 9.48 |
| Ipca Laboratories | 0.20 | 5.23 | 16.29 | 4.09 | -4.50 | 20.47 | 7.15 |
| Anthem Biosciences | -5.04 | -10.91 | -19.39 | -14.75 | -14.75 | -5.18 | -3.14 |
| Ajanta Pharma | -5.19 | 2.50 | 13.06 | 2.12 | -3.90 | 32.03 | 18.10 |
| Emcure Pharmaceuticals | 3.04 | 12.71 | 17.50 | 16.15 | 16.47 | 5.02 | 2.98 |
Over the last one year, Neuland Laboratories has gained 7.21% compared to peers like Sun Pharmaceutical Industries (-3.86%), Divi's Laboratories (5.88%), Torrent Pharmaceuticals (23.01%). From a 5 year perspective, Neuland Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (22.88%) and Divi's Laboratories (11.26%).
Neuland Laboratories Financials
Neuland Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 14,780.94 | 14,658.45 |
| 10 | 14,947.52 | 14,845.08 |
| 20 | 15,287 | 15,183.48 |
| 50 | 16,274.71 | 15,638.95 |
| 100 | 15,679.03 | 15,389.68 |
| 200 | 14,062.94 | 14,512.96 |
Neuland Laboratories Share Holding Pattern
In the latest quarter, Neuland Laboratories saw a drop in promoter holding to 32.63%, while DII stake increased to 14.72%, FII holding rose to 20.90%, and public shareholding moved down to 31.76% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Neuland Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,70,843 | 2.33 | 468.23 | |
| 1,61,718 | 1.73 | 279.58 | |
| 64,583 | 2.64 | 111.65 | |
| 55,227 | 1.56 | 95.48 | |
| 54,813 | 0.52 | 94.76 | |
| 44,855 | 2.25 | 77.55 | |
| 27,800 | 1.72 | 48.06 | |
| 25,861 | 1.59 | 44.71 | |
| 25,605 | 0.69 | 44.27 | |
| 25,000 | 2.51 | 43.22 |
* Excluding Index & Arbitrage Funds
Neuland Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 02, 2026, 11:13 PM IST | Neuland Laborat - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 02, 2026, 10:56 PM IST | Neuland Laborat - Re-Lodgement Of Transfer Request Of Physical Shares |
| Dec 15, 2025, 2:32 PM IST | Neuland Laborat - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Dec 09, 2025, 11:15 PM IST | Neuland Laborat - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Dec 08, 2025, 6:20 AM IST | Neuland Laborat - Re-Lodgement Of Transfer Request Of Physical Shares |
About Neuland Laboratories
Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1476.84 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address11th Floor (5th Office Level), Phoenix IVY Building, Hyderabad Telangana 500033
- Contact
Management
- Dr. Davuluri Rama Mohan RaoExecutive Chairman
- Mr. Davuluri Sucheth RaoVice Chairman & CEO
- Mr. Davuluri Saharsh RaoVice Chairman & Mng.Director
- Dr. Christopher M CimarustiNon Executive Director
- Mr. Homi Rustum KhusrokhanInd. Non-Executive Director
- Mr. Prasad Raghava MenonInd. Non-Executive Director
- Mr. Sugata SircarInd. Non-Executive Director
- Ms. Pallavi Joshi BakhruInd. Non-Executive Director
FAQs on Neuland Laboratories Share Price
What is the share price of Neuland Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Neuland Laboratories is ₹14,247.55 as on Jan 14, 2026.
What kind of stock is Neuland Laboratories?
The Neuland Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Neuland Laboratories?
The market cap of Neuland Laboratories is ₹18,279.45 Cr as on Jan 14, 2026.
What are today's High and Low prices of Neuland Laboratories?
Today’s highest and lowest price of Neuland Laboratories are ₹14,710.20 and ₹14,159.20.
What are the 52 Week High and 52 Week Low of Neuland Laboratories?
The 52-week high/low is the highest and lowest price at which Neuland Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Neuland Laboratories is ₹19,748.40 and 52-week low of Neuland Laboratories is ₹10,060.00 as on Jan 14, 2026.
How has the Neuland Laboratories performed historically in terms of returns?
The Neuland Laboratories has shown returns of -0.6% over the past day, -13.24% for the past month, -12.55% over 3 months, 7.21% over 1 year, 104.47% across 3 years, and 62.69% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Neuland Laboratories?
P/E ratio of and PB ratio of Neuland Laboratories are 76.12 and 11.28 on Jan 14, 2026. While the company gives a dividend yield of 0.08 per annum.
✕
Market Pulse